Skip to main content
Top
Published in: AIDS and Behavior 11/2018

01-11-2018 | Original Paper

Poppers and PrEP: Use of Pre-exposure Prophylaxis Among Men Who Have Sex with Men Who Use Inhaled Nitrites

Authors: H. Rhodes Hambrick, Su Hyun Park, John A. Schneider, Kenneth H. Mayer, Adam W. Carrico, Scott E. Sherman, Dustin T. Duncan

Published in: AIDS and Behavior | Issue 11/2018

Login to get access

Abstract

Men who have sex with men (MSM) commonly use inhaled nitrites, or poppers, though their use is a risk factor HIV seroconversion. Pre-exposure prophylaxis, or PrEP, is effective for HIV prevention, but is not widely used, and little is known regarding PrEP use and acceptability among MSM who use inhaled nitrites. We surveyed 580 MSM in Paris, France in 2016 about popper use, sexual behaviors including condomless anal intercourse (CAI), serosorting, and sexual positioning, PrEP use, PrEP candidacy, and interest in alternate PrEP delivery modalities. We included 444 HIV negative participants for the current study. 46.2% reported popper use in the prior 3 months. Using multivariate adjusted logistic regression, we found that popper users were more likely than non-users to consider themselves candidates for PrEP [adjusted relative risk ratio (aRRR) = 2.73; 95% CI 1.54–4.83], but they were not more likely to be current (aRRR = 1.54; 95% CI 0.71–3.33) or past (aRRR = 1.37; 95% CI 0.44–4.28) PrEP users. Mediation analyses indicated that increased CAI and serosorting partly explained the relationship between popper use and PrEP candidacy. There was considerable interest in alternate proposed PrEP delivery modalities, particularly long-acting injectable PrEP [adjusted risk ratio (aRR) = 1.43; 95% CI 1.15–1.79].
Literature
1.
go back to reference European Centre for Disease Prevention and Control. Men who have sex with men: monitoring implementation of the dublin declaration on partnership to fight HIV/AIDS in Europe and central Asia: 2014 progress report. Stockholm: European Centre for Disease Prevention and Control; 2015. European Centre for Disease Prevention and Control. Men who have sex with men: monitoring implementation of the dublin declaration on partnership to fight HIV/AIDS in Europe and central Asia: 2014 progress report. Stockholm: European Centre for Disease Prevention and Control; 2015.
2.
go back to reference European Centre for Disease Prevention and Control. HIV and men who have sex with men. Stockholm: European Centre for Disease Prevention and Control; 2017. European Centre for Disease Prevention and Control. HIV and men who have sex with men. Stockholm: European Centre for Disease Prevention and Control; 2017.
3.
go back to reference Marcus U, Hickson F, Weatherburn P, Schmidt AJ. Esitmating the size of the MSM populations for 38 European countries by calculating the survey-surveillance discrepancies (SSD) between self-reported new HIV diagnoses from the European MSM internet survey (EMIS) and surveillance-reported HIV diagnoses among MSM in 2009. BMC Public Health. 2009;13(1):919.CrossRef Marcus U, Hickson F, Weatherburn P, Schmidt AJ. Esitmating the size of the MSM populations for 38 European countries by calculating the survey-surveillance discrepancies (SSD) between self-reported new HIV diagnoses from the European MSM internet survey (EMIS) and surveillance-reported HIV diagnoses among MSM in 2009. BMC Public Health. 2009;13(1):919.CrossRef
4.
go back to reference European Centre for Disease Prevention and Control. HIV/AIDS surveillance in Europe, 2015. Stockholm: European Centre for Disease Prevention and Control; 2016. European Centre for Disease Prevention and Control. HIV/AIDS surveillance in Europe, 2015. Stockholm: European Centre for Disease Prevention and Control; 2016.
6.
go back to reference Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemophrophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRef Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemophrophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRef
7.
go back to reference McCormack SM, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.CrossRef McCormack SM, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.CrossRef
8.
go back to reference Molina J-M, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I. On-demand pre-exposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRef Molina J-M, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I. On-demand pre-exposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRef
9.
go back to reference Molina J-M. PrEP roll-out in France. In: World AIDS conference. South Africa: Durban; 2016. Molina J-M. PrEP roll-out in France. In: World AIDS conference. South Africa: Durban; 2016.
10.
go back to reference Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012;11(7):CD007189. Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012;11(7):CD007189.
11.
go back to reference Gomez GB, Borquez A, Case KK, Wheelock A, Vassal A, Hankins C. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med. 2013;10(3):e1001401.CrossRef Gomez GB, Borquez A, Case KK, Wheelock A, Vassal A, Hankins C. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med. 2013;10(3):e1001401.CrossRef
12.
go back to reference Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “Truvada whores”. Am J Public Health. 2015;105(10):1960–4.CrossRef Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “Truvada whores”. Am J Public Health. 2015;105(10):1960–4.CrossRef
13.
go back to reference Grant RM, Anderson PL, McMahan V, Liu AY, Amico KR, Mehrota M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.CrossRef Grant RM, Anderson PL, McMahan V, Liu AY, Amico KR, Mehrota M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.CrossRef
14.
go back to reference European AIDS Clinical Society. European AIDS Clinical Society Guidelines. Copenhagen: European AIDS Clinical Society; 2015. European AIDS Clinical Society. European AIDS Clinical Society Guidelines. Copenhagen: European AIDS Clinical Society; 2015.
15.
go back to reference Center for Disease Control and Prevention. Pre-exposure prophylaxis (PrEP) for HIV prevention. 2014. Center for Disease Control and Prevention. Pre-exposure prophylaxis (PrEP) for HIV prevention. 2014.
16.
go back to reference Crosby RA. Condom use as a dependent variable: measurement issues relevant to HIV prevention programs. AIDS Educ Prev. 1998;10(6):548–57.PubMed Crosby RA. Condom use as a dependent variable: measurement issues relevant to HIV prevention programs. AIDS Educ Prev. 1998;10(6):548–57.PubMed
17.
go back to reference Lowndes CM, Jayachandran AA, Branandur P, Ramesh BM, Washington R, Sangameshwar BM. Polling booth surveys: a novel approach for reducing social desirability bias in HIV-related behavioural surveys in resource-poor settings. AIDS Behav. 2012;16(4):1054–62.CrossRef Lowndes CM, Jayachandran AA, Branandur P, Ramesh BM, Washington R, Sangameshwar BM. Polling booth surveys: a novel approach for reducing social desirability bias in HIV-related behavioural surveys in resource-poor settings. AIDS Behav. 2012;16(4):1054–62.CrossRef
18.
go back to reference Phillips AE, Gomez GB, Boily MC, Garnett GP. A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low- and middle-income countries. Int J Epidemiol. 2010;39(6):1541–55.CrossRef Phillips AE, Gomez GB, Boily MC, Garnett GP. A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low- and middle-income countries. Int J Epidemiol. 2010;39(6):1541–55.CrossRef
19.
go back to reference Phillips AE, Molitor J, Boily MC, Lowndres CM, Gurav K, Blanchard J. Informal confidential voting interviewing in a sexual risk assessment of men who have sex with men (MSM) and transgenders (hijra) in Bangalore, India. Sex Transm Infect. 2013;89(3):245–50.CrossRef Phillips AE, Molitor J, Boily MC, Lowndres CM, Gurav K, Blanchard J. Informal confidential voting interviewing in a sexual risk assessment of men who have sex with men (MSM) and transgenders (hijra) in Bangalore, India. Sex Transm Infect. 2013;89(3):245–50.CrossRef
20.
go back to reference Hatfield LA, Horvath KJ, Jacoby SM, Rosser BRS. Comparison of substance use and risky sexual behaivor among a diverse sample of urban, HIV-positive men who have sex with men. J Addict Dis. 2009;28(3):208–18.CrossRef Hatfield LA, Horvath KJ, Jacoby SM, Rosser BRS. Comparison of substance use and risky sexual behaivor among a diverse sample of urban, HIV-positive men who have sex with men. J Addict Dis. 2009;28(3):208–18.CrossRef
21.
go back to reference Lampinen TM, Mattheis K, Chan K, Hogg RS. Nitrite inhalant use among young gay and bisexual men in Vancouver during a period of increasing HIV incidence. BMC Public Health. 2007;7:35–40.CrossRef Lampinen TM, Mattheis K, Chan K, Hogg RS. Nitrite inhalant use among young gay and bisexual men in Vancouver during a period of increasing HIV incidence. BMC Public Health. 2007;7:35–40.CrossRef
22.
go back to reference Schmidt AJ, Bourne A, Weatherburn P, Reid D, Marcus U, Hickson F, et al. Illicit drug use among gay and bisexual men in 44 cities: findings from the European MSM Internet Survey (EMIS). Int J Drug Policy. 2016;38:4–12.CrossRef Schmidt AJ, Bourne A, Weatherburn P, Reid D, Marcus U, Hickson F, et al. Illicit drug use among gay and bisexual men in 44 cities: findings from the European MSM Internet Survey (EMIS). Int J Drug Policy. 2016;38:4–12.CrossRef
23.
go back to reference Zhao P, Tang S, Wang C, Zhang Y, Best J, Tangthanasup TM, et al. Recreational drug use among Chinese MSM and transgender individuals: results from a national online cross-sectional study. PLoS ONE. 2017;12(1):e0170024.CrossRef Zhao P, Tang S, Wang C, Zhang Y, Best J, Tangthanasup TM, et al. Recreational drug use among Chinese MSM and transgender individuals: results from a national online cross-sectional study. PLoS ONE. 2017;12(1):e0170024.CrossRef
24.
go back to reference Colfax G, Coates TJ, Husnik MJ, Huang Y, Buchbinder S, Koblin B, et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san franciscso men who have sex with men. J Urban Health. 2005;82(1 Suppl 1):i62–70.CrossRef Colfax G, Coates TJ, Husnik MJ, Huang Y, Buchbinder S, Koblin B, et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san franciscso men who have sex with men. J Urban Health. 2005;82(1 Suppl 1):i62–70.CrossRef
25.
go back to reference Colfax G, Vittinghoff E, Husnik MJ, McKirnan D, Buchbinder S, Koblin B, et al. Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol. 2004;159(10):1002–12.CrossRef Colfax G, Vittinghoff E, Husnik MJ, McKirnan D, Buchbinder S, Koblin B, et al. Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol. 2004;159(10):1002–12.CrossRef
26.
go back to reference Daskalopoulou M, Rodger A, Phillips AN, Sherr L, Speakman A, Collins S, et al. Recreational drug use, polydrug use, and sexual behavior in HIV-diagnosed men who have sex with men in the UK: results form the cross-sectional ASTRA study. Lancet HIV. 2014;1(1):e22–31.CrossRef Daskalopoulou M, Rodger A, Phillips AN, Sherr L, Speakman A, Collins S, et al. Recreational drug use, polydrug use, and sexual behavior in HIV-diagnosed men who have sex with men in the UK: results form the cross-sectional ASTRA study. Lancet HIV. 2014;1(1):e22–31.CrossRef
27.
go back to reference Zhang H, Teng T, Lu H, Zhao Y, Liu H, Yin L, et al. Poppers use and risky sexual behaviors among men hwo have sex with men in Beijing, China. Drug Alcohol Depend. 2016;160:42–8.CrossRef Zhang H, Teng T, Lu H, Zhao Y, Liu H, Yin L, et al. Poppers use and risky sexual behaviors among men hwo have sex with men in Beijing, China. Drug Alcohol Depend. 2016;160:42–8.CrossRef
28.
go back to reference Ferrer L, Furegato M, Foschia JP, Folch C, González V, Ramarli D, et al. Undiagnosed HIV infection in a population of MSM from six European cities: results from the Sialon project. Eur J Public Health. 2015;25(3):494–500.CrossRef Ferrer L, Furegato M, Foschia JP, Folch C, González V, Ramarli D, et al. Undiagnosed HIV infection in a population of MSM from six European cities: results from the Sialon project. Eur J Public Health. 2015;25(3):494–500.CrossRef
29.
go back to reference Mayer KH, O’Cleirigh C, Skeer M, Covahey C, Leidolf E, Vanderwarker R, et al. Which HIV-infected men who have sex with men in care are engaging in risky sex and acquiring sexually transmitted infections: findings from a Boston community health centre. Sex Transm Infect. 2010;86(1):66–70.CrossRef Mayer KH, O’Cleirigh C, Skeer M, Covahey C, Leidolf E, Vanderwarker R, et al. Which HIV-infected men who have sex with men in care are engaging in risky sex and acquiring sexually transmitted infections: findings from a Boston community health centre. Sex Transm Infect. 2010;86(1):66–70.CrossRef
30.
go back to reference Xu J, Qian H, Chu Z, Zhang J, Hu Q, Jiang Y, et al. Recreational drug use among Chinese men who have sex with men: a risky combination with unprotected sex for acquiring HIV infection. Biomed Res Int. 2014;2014(725361):1–9. Xu J, Qian H, Chu Z, Zhang J, Hu Q, Jiang Y, et al. Recreational drug use among Chinese men who have sex with men: a risky combination with unprotected sex for acquiring HIV infection. Biomed Res Int. 2014;2014(725361):1–9.
31.
go back to reference Ostrow DG, Plankey MW, Cox C, Li X, Shoptaw S, Jacobson LP, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr. 2009;51(3):349–55.CrossRef Ostrow DG, Plankey MW, Cox C, Li X, Shoptaw S, Jacobson LP, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr. 2009;51(3):349–55.CrossRef
32.
go back to reference Plankey MW, Ostrow DG, Stall R, Cox C, Li X, Peck JA. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2007;45:85–92.CrossRef Plankey MW, Ostrow DG, Stall R, Cox C, Li X, Peck JA. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2007;45:85–92.CrossRef
33.
go back to reference Hambrick HR, Park SH, Palamar JJ, Estreet A, Schneider JA, Duncan DT. Use of poppers and HIV risk behaviours among men who have sex with men in Paris, France: an observational study. Sexual Health. 2018 (in press). Hambrick HR, Park SH, Palamar JJ, Estreet A, Schneider JA, Duncan DT. Use of poppers and HIV risk behaviours among men who have sex with men in Paris, France: an observational study. Sexual Health. 2018 (in press).
34.
go back to reference Bracchi M, Stuart D, Castles R, Khoo S, Back D, Boffito M. Increasing use of ‘party drugs’ in people living with HIV on antiretrovirals: a concern for patient safety. AIDS. 2015;29(13):1585–92.CrossRef Bracchi M, Stuart D, Castles R, Khoo S, Back D, Boffito M. Increasing use of ‘party drugs’ in people living with HIV on antiretrovirals: a concern for patient safety. AIDS. 2015;29(13):1585–92.CrossRef
35.
go back to reference Hunter LJ, Dargan PI, Benzie A, White JA, Wood DM. Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM. Postgrad Med J. 1061;2014(90):133–8. Hunter LJ, Dargan PI, Benzie A, White JA, Wood DM. Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM. Postgrad Med J. 1061;2014(90):133–8.
36.
go back to reference Duncan DT, Goedel WC, Mayer KH, Safren SA, Palamar JJ, Hagen DL, et al. Poor sleep health and its association with mental health, substance use, and condomless anal intercourse among gay, bisexual, and other men who have sex with men. Sleep Health. 2016;2(4):316–21.CrossRef Duncan DT, Goedel WC, Mayer KH, Safren SA, Palamar JJ, Hagen DL, et al. Poor sleep health and its association with mental health, substance use, and condomless anal intercourse among gay, bisexual, and other men who have sex with men. Sleep Health. 2016;2(4):316–21.CrossRef
37.
go back to reference Harkness J. Questionnaire translation. In: Harkness J, Van de Vijer F, Moher P, editors. Cross-cultural survey methods. Hoboken: Wiley; 2003. Harkness J. Questionnaire translation. In: Harkness J, Van de Vijer F, Moher P, editors. Cross-cultural survey methods. Hoboken: Wiley; 2003.
38.
go back to reference Grov C, Whitfield THF, Rendina HJ, Ventuneac A, Parsons JT. Willingness to take PrEP and potenital for risk compensation among highly sexually active gay and bisexual men. AIDS Behav. 2015;19(12):2234–44.CrossRef Grov C, Whitfield THF, Rendina HJ, Ventuneac A, Parsons JT. Willingness to take PrEP and potenital for risk compensation among highly sexually active gay and bisexual men. AIDS Behav. 2015;19(12):2234–44.CrossRef
39.
go back to reference Hoagland B, De Boni RB, Moreira RI, et al. Awareness and Willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil. AIDS Behav. 2017;21(5):1278–87.CrossRef Hoagland B, De Boni RB, Moreira RI, et al. Awareness and Willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil. AIDS Behav. 2017;21(5):1278–87.CrossRef
40.
go back to reference Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.PubMedPubMedCentral Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.PubMedPubMedCentral
41.
go back to reference Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.CrossRef Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.CrossRef
43.
go back to reference Zhao K, editor. Proper estimation of relative risk using PROC GENMOD in population studies. Las Vegas: Western Users of SAS Software; 2013. Zhao K, editor. Proper estimation of relative risk using PROC GENMOD in population studies. Las Vegas: Western Users of SAS Software; 2013.
44.
go back to reference Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–806.CrossRef Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–806.CrossRef
45.
go back to reference Yelland LN, Salter AB, Ryan P. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol. 2011;174(8):984–92.CrossRef Yelland LN, Salter AB, Ryan P. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol. 2011;174(8):984–92.CrossRef
47.
go back to reference Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediatior interactions and causal interpretation: theoretical assumptions and impelementation with SAS and SPSS macros. Psychol Methods. 2013;18(2):137–50.CrossRef Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediatior interactions and causal interpretation: theoretical assumptions and impelementation with SAS and SPSS macros. Psychol Methods. 2013;18(2):137–50.CrossRef
48.
go back to reference Kelley CF, Kahle E, Siegler A, Sanchez T, Del Rio C, Sullivan PS, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–7.CrossRef Kelley CF, Kahle E, Siegler A, Sanchez T, Del Rio C, Sullivan PS, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–7.CrossRef
50.
go back to reference Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–67.CrossRef Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–67.CrossRef
52.
go back to reference Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. J Acquir Immune Defic Syndr. 2017;74(3):285–92.CrossRef Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. J Acquir Immune Defic Syndr. 2017;74(3):285–92.CrossRef
54.
go back to reference Greene GJ, Swann G, Fought AJ, Carballo-Dieguez A. Preferences for long-acting pre-exposure prophylaxis (PrEP), daily oral PrEP, or condoms for HIV prevention among U.S. men who have sex with men. AIDS Behav. 2017;21(5):1336–49.CrossRef Greene GJ, Swann G, Fought AJ, Carballo-Dieguez A. Preferences for long-acting pre-exposure prophylaxis (PrEP), daily oral PrEP, or condoms for HIV prevention among U.S. men who have sex with men. AIDS Behav. 2017;21(5):1336–49.CrossRef
55.
go back to reference Levy ME, Patrick R, Gamble J, Rawls A, Opoku J, Magnus M, et al. Willingness of communinty-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis. PLoS ONE. 2017;12(8):e0183521.CrossRef Levy ME, Patrick R, Gamble J, Rawls A, Opoku J, Magnus M, et al. Willingness of communinty-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis. PLoS ONE. 2017;12(8):e0183521.CrossRef
56.
go back to reference Meyers K, Rodriguez K, Moeller RW, Gratch I, Markowitz M, Halkitis PN. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy. PLoS ONE. 2014;9(12):e114700.CrossRef Meyers K, Rodriguez K, Moeller RW, Gratch I, Markowitz M, Halkitis PN. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy. PLoS ONE. 2014;9(12):e114700.CrossRef
57.
go back to reference Parsons JT, Rendina HJ, Whitfield TH, Grov C. Familiarity with and preferences for oral and long-acting injectable HIV pre-exposure prophylaxis (PrEP) in a national sample of gay and bisexual men in the U.S. AIDS Behav. 2016;20(7):1390–9.CrossRef Parsons JT, Rendina HJ, Whitfield TH, Grov C. Familiarity with and preferences for oral and long-acting injectable HIV pre-exposure prophylaxis (PrEP) in a national sample of gay and bisexual men in the U.S. AIDS Behav. 2016;20(7):1390–9.CrossRef
60.
go back to reference Wang Z, Lau JTF, Yang X, Cai Y, Gross DL, Ma T, et al. Acceptability of daily use of free oral pre-exposure prophylaxis (PrEP) among transgender women sex workers in Shenyang, China. AIDS Behav. 2017;21(12):3287–98.CrossRef Wang Z, Lau JTF, Yang X, Cai Y, Gross DL, Ma T, et al. Acceptability of daily use of free oral pre-exposure prophylaxis (PrEP) among transgender women sex workers in Shenyang, China. AIDS Behav. 2017;21(12):3287–98.CrossRef
61.
go back to reference Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):e005717.CrossRef Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):e005717.CrossRef
62.
go back to reference Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325–35.CrossRef Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325–35.CrossRef
63.
go back to reference Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21580.CrossRef Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21580.CrossRef
64.
go back to reference Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRef Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRef
65.
go back to reference Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992;111(3):455–74.CrossRef Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992;111(3):455–74.CrossRef
66.
go back to reference Fisher JD, Fisher WA, Williams SS, Malloy TE. Empirical tests of an information-motivation-behavioral skills model of AIDS-preventive behavior with gay men and heterosexual university students. Health Psychol. 1994;13(3):238–50.CrossRef Fisher JD, Fisher WA, Williams SS, Malloy TE. Empirical tests of an information-motivation-behavioral skills model of AIDS-preventive behavior with gay men and heterosexual university students. Health Psychol. 1994;13(3):238–50.CrossRef
67.
go back to reference Rongkavilit C, Naar-King S, Kaljee LM, Panthong A, Koken JA, Bunupuradah T, et al. Applying the infromation-motivation-behavioral skills model in medication adherence among Thai youth living with HIV: a qualitative study. AIDS Patient Care STDS. 2010;24(12):787–94.CrossRef Rongkavilit C, Naar-King S, Kaljee LM, Panthong A, Koken JA, Bunupuradah T, et al. Applying the infromation-motivation-behavioral skills model in medication adherence among Thai youth living with HIV: a qualitative study. AIDS Patient Care STDS. 2010;24(12):787–94.CrossRef
68.
go back to reference Aliabadi N, Carballo-Dieguez A, Bakken S, Rojas M, Wr Brown, Carry M, et al. Using the information-motivation-behavioral skills model to guide the development of an HIV prevention smartphone application for high-risk MSM. AIDS Educ Prev. 2015;27(6):522–37.CrossRef Aliabadi N, Carballo-Dieguez A, Bakken S, Rojas M, Wr Brown, Carry M, et al. Using the information-motivation-behavioral skills model to guide the development of an HIV prevention smartphone application for high-risk MSM. AIDS Educ Prev. 2015;27(6):522–37.CrossRef
Metadata
Title
Poppers and PrEP: Use of Pre-exposure Prophylaxis Among Men Who Have Sex with Men Who Use Inhaled Nitrites
Authors
H. Rhodes Hambrick
Su Hyun Park
John A. Schneider
Kenneth H. Mayer
Adam W. Carrico
Scott E. Sherman
Dustin T. Duncan
Publication date
01-11-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 11/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2139-9

Other articles of this Issue 11/2018

AIDS and Behavior 11/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.